Biogen Tax on Share Settlement increased by 126.7% to $55.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 126.7%, from $24.30M to $55.10M. This increase may warrant attention — for this metric, lower values are generally preferred.
Increases generally correlate with higher levels of stock-based compensation and the timing of equity award vesting cycles.
Cash payments made by the company to tax authorities on behalf of employees to cover withholding taxes triggered by the...
Commonly reported by technology companies with significant stock-based compensation programs.
taxes_paid_for_shares| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $20.80M | $60.10M | $46.90M | $24.30M | $55.10M |
| QoQ Change | — | +188.9% | -22.0% | -48.2% | +126.7% |
| YoY Change | — | +188.9% | -22.0% | -48.2% | +126.7% |